Orchestra BioMed Holdings (OBIO) Non-cash Items (2023 - 2026)

Orchestra BioMed Holdings (OBIO) has 4 years of Non-cash Items data on file, last reported at $4.5 million in Q1 2026.

• Quarterly Non-cash Items rose 22.18% year-over-year to $4.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.5 million (up 22.18% YoY) and the FY2025 annual result came in at $4.4 million, up 26.56% from the prior year.
• Non-cash Items rose to $4.5 million in Q1 2026 per OBIO's latest filing, from $2.0 million in the prior quarter.
• Across five years, Non-cash Items topped out at $8.2 million in Q4 2023 and bottomed at $3000.0 in Q4 2024.
• The 4-year median for Non-cash Items is $2.9 million (2024), against an average of $3.5 million.
• The widest annual swing landed in 2024, when Non-cash Items sank 99.96%; it then surged 65333.33% in 2025.
• Tracing OBIO's Non-cash Items over 4 years: stood at $8.2 million in 2023, then tumbled by 99.96% to $3000.0 in 2024, then surged by 65333.33% to $2.0 million in 2025, then surged by 127.27% to $4.5 million in 2026.
• Per Business Quant, the three latest OBIO Non-cash Items figures stand at $4.5 million (Q1 2026), $2.0 million (Q4 2025), and $359000.0 (Q3 2025).

Peer Comparison